van Dijk, J. W, Eijsvogels, T. M, Nyakayiru, J., Schreuder, T. H, Hopman, M. T, Thijssen, D. H & Van Loon, L. (2016). Glycemic control during consecutive days with prolongedwalking exercise in individuals with type 1 diabetes mellitus. Diabetes Research and Clinical Practice,117 74-81. Ireland: Elsevier Ireland Ltd.. Retrieved from https://doi.org/10.1016/j.diabres.2016.04.053
Aims Despite its general benefits for health, exercise complicates the maintenance of stable blood glucose concentrations in individuals with type 1 diabetes. The aim of the current study was to examine changes in food intake, insulin administration, and 24-h glycemic control in response to consecutive days with prolonged walking exercise (∼8 h daily) in individuals with type 1 diabetes. Methods Ten individuals with type 1 diabetes participating in the worlds’ largest walking event were recruited for this observational study. Simultaneous measurements of 24-h glycemic control (continuous glucose monitoring), insulin administration and food intake were performed during a non-walking day (control) and during three subsequent days with prolonged walking exercise (daily distance 40 or 50 km). Results Despite an increase in daily energy (31 ± 18%; p < 0.01) and carbohydrate (82 ± 71 g; p < 0.01) intake during walking days, subjects lowered their insulin administration by 26 ± 16% relative to the control day (p < 0.01). Average 24-h blood glucose concentrations, the prevalence of hyperglycemia (blood glucose >10 mmol/L) and hypoglycemia (blood glucose <3.9 mmol/L) did not differ between the control day and walking days (p > 0.05 for all variables). The prolonged walking exercise was associated with a modest increase in glycemic variability compared with the control day (p < 0.05). Conclusion Prolonged walking exercise allows for profound reductions in daily insulin administration in persons with type 1 diabetes, despite large increments in energy and carbohydrate intake. When taking such adjustments into account, prolonged moderate-intensity exercise does not necessarily impair 24-h glycemic control.
Mary MacKillop Institute for Health Research
Access may be restricted.